Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer

Figure 4 TP53INP1 expression and patient survival by Kaplan-Meier analysis. A: Survival curves for TP53INP1-positive and negative gastric cancers. The 60-mo survival rates were 74.7% and 54.9%, respectively. The difference between the values was highly significant (P = 0.0006). B: In well or moderately differentiated adenocarcinoma (intestinal-type), the survival of TP53INP1-positive patients was not significantly different from that of TP53INP1-negative group (P = 0.1110). C: In poorly differentiated adenocarcinoma (diffuse-type), the 60-mo patient survival rates were 62.1% and 45.9% for TP53INP1-positive and -negative gastric cancers, respectively. This difference was statistically significant (P = 0.0199).